LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

March 16, 2024

Primary Completion Date

March 16, 2025

Study Completion Date

March 16, 2026

Conditions
Sickle Cell DiseasePregnancy RelatedPregnancy ComplicationsPre-Eclampsia
Interventions
DRUG

Aspirin 100mg

Daily use of low dose aspirin.

Trial Locations (1)

00000

RECRUITING

Instituto Nacional de Investigação Em Saúde, Luanda

All Listed Sponsors
collaborator

FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA

UNKNOWN

collaborator

FUNDAÇAO CALOUSTE GULBENKIAN

UNKNOWN

collaborator

CLINCOORD SERVICES, INC.

UNKNOWN

collaborator

CLINCOORD PRESTAÇÃO DE SEVIÇOS, LDA ANGOLA

UNKNOWN

collaborator

Escola Superior de Tecnologia da Saúde de Lisboa

OTHER

collaborator

ClinCoord Research Center at Luanda Medical Center

UNKNOWN

lead

Instituto Nacional de Investigacao em Saude, Angola

OTHER_GOV